Fosaprepitant Intravenous and Insulin glulisine Subcutaneous
Determining the interaction of Fosaprepitant Intravenous and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant Intravenous-Insulin human inhaled Inhalation
- Fosaprepitant Intravenous-Insulin human regular Injection
- Fosaprepitant Intravenous-Insulin inhalation
- Fosaprepitant Intravenous-Insulin isophane
- Fosaprepitant Intravenous-Insulin isophane and insulin regular
- Fosaprepitant Intravenous-Insulin lispro
- Insulin glulisine Subcutaneous-Foscarnet
- Insulin glulisine Subcutaneous-Foscarnet Intravenous
- Insulin glulisine Subcutaneous-Foscarnet Sodium
- Insulin glulisine Subcutaneous-Foscavir
- Insulin glulisine Subcutaneous-Fosfomycin
- Insulin glulisine Subcutaneous-Fosfomycin Tromethamine